105 related articles for article (PubMed ID: 1362538)
1. Allele diversity of the H-ras-1 variable number of tandem repeats in Norwegian lung cancer patients.
Ryberg D; Tefre T; Skaug V; Stangeland L; Ovrebø S; Naalsund A; Børresen AL; Haugen A
Environ Health Perspect; 1992 Nov; 98():187-9. PubMed ID: 1362538
[TBL] [Abstract][Full Text] [Related]
2. Ha-ras-1 alleles in Norwegian lung cancer patients.
Ryberg D; Tefre T; Ovrebø S; Skaug V; Stangeland L; Naalsund A; Baera R; Børresen AL; Haugen A
Hum Genet; 1990 Nov; 86(1):40-4. PubMed ID: 1979305
[TBL] [Abstract][Full Text] [Related]
3. Rare Ha-ras1 alleles and predisposition to testicular cancer.
Ryberg D; Heimdal K; Fosså SD; Børresen AL; Haugen A
Int J Cancer; 1993 Apr; 53(6):938-40. PubMed ID: 8097187
[TBL] [Abstract][Full Text] [Related]
4. Hypomethylation of CCGG sites in the 3' region of H-ras protooncogene is frequent and is associated with H-ras allele loss in non-small cell lung cancer.
Vachtenheim J; Horáková I; Novotná H
Cancer Res; 1994 Mar; 54(5):1145-8. PubMed ID: 8118795
[TBL] [Abstract][Full Text] [Related]
5. Association of rare alleles of the Harvey ras protooncogene locus with lung cancer.
Sugimura H; Caporaso NE; Modali RV; Hoover RN; Resau JH; Trump BF; Longergan JA; Krontiris TG; Mann DL; Weston A
Cancer Res; 1990 Mar; 50(6):1857-62. PubMed ID: 2407346
[TBL] [Abstract][Full Text] [Related]
6. [Restriction polymorphism of the proto-oncogene c-Ha-ras-1 in patients with multiple primary malignant neoplasms and non-small-cell lung cancer].
Gaspar'ian AV; Sel'chuk VIu; Iakubovskaia MG; Zborovskaia IB; Tatosian AG
Genetika; 1997 Jan; 33(1):96-100. PubMed ID: 9162692
[TBL] [Abstract][Full Text] [Related]
7. Distribution and rearrangements of alleles of c-Ha-ras-1 protooncogene and their correlation with the development of lung, ovarian and thyroid cancers.
Knyazev PG; Nikiforova IF; Serova OM; Pluzhnikova GF
Neoplasma; 1990; 37(6):647-55. PubMed ID: 1980342
[TBL] [Abstract][Full Text] [Related]
8. H-ras-1 restriction fragment length polymorphism in normal individuals and oral cancer patients in India.
Bhoite LT; Saranath D; Nair R; Deo MG; Sanghavi V; Mehta A
J Oral Pathol Med; 1993 Aug; 22(7):298-302. PubMed ID: 7901404
[TBL] [Abstract][Full Text] [Related]
9. Loss of allelic heterozygosity at the harvey ras locus in human oral carcinomas.
Saranath D; Bhoite LT; Mehta AR; Sanghavi V; Deo MG
J Cancer Res Clin Oncol; 1991; 117(5):484-8. PubMed ID: 1679760
[TBL] [Abstract][Full Text] [Related]
10. Genetic susceptibility associated with rare HRAS1 variable number of tandem repeats alleles in Spanish non-small cell lung cancer patients.
Rosell R; Calvo R; Sánchez JJ; Maurel J; Guillot M; Monzó M; Núñez L; Barnadas A
Clin Cancer Res; 1999 Jul; 5(7):1849-54. PubMed ID: 10430091
[TBL] [Abstract][Full Text] [Related]
11. Racial variation in the distribution of Ha-ras-1 alleles.
Weston A; Vineis P; Caporaso NE; Krontiris TG; Lonergan JA; Sugimura H
Mol Carcinog; 1991; 4(4):265-8. PubMed ID: 1714739
[TBL] [Abstract][Full Text] [Related]
12. Increased frequency of specific alleles of the c-Ha-ras gene in Japanese cancer patients.
Honda K; Ishizaki K; Ikenaga M; Toguchida J; Inamoto T; Tanaka K; Ozawa K
Hum Genet; 1988 Aug; 79(4):297-300. PubMed ID: 2900800
[TBL] [Abstract][Full Text] [Related]
13. c-Ha-ras polymorphism in patients with hepatocellular carcinoma. Comparison of healthy subjects and alcoholic patients with cirrhosis.
Thelu MA; Zarski JP; Froissart B; Rachail M; Seigneurin JM
Gastroenterol Clin Biol; 1993; 17(12):903-7. PubMed ID: 7907302
[TBL] [Abstract][Full Text] [Related]
14. The second intron of the K-ras gene contains regulatory elements associated with mouse lung tumor susceptibility.
Chen B; Johanson L; Wiest JS; Anderson MW; You M
Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1589-93. PubMed ID: 8108449
[TBL] [Abstract][Full Text] [Related]
15. Human hypervariable sequences in risk assessment: rare Ha-ras alleles in cancer patients.
Krontiris TG; DiMartino NA; Mitcheson HD; Lonergan JA; Begg C; Parkinson DR
Environ Health Perspect; 1987 Dec; 76():147-53. PubMed ID: 3329095
[TBL] [Abstract][Full Text] [Related]
16. Ha-ras polymorphisms in epithelial ovarian cancer.
O'Briant K; Chrysson N; Hunter V; Tyson F; Tanner M; Daly L; George SL; Berchuck A; Soper J; Fowler W
Gynecol Oncol; 1992 Jun; 45(3):299-302. PubMed ID: 1351862
[TBL] [Abstract][Full Text] [Related]
17. [The role of the constitutional features and rearrangement of the H-ras 1 oncogene in the development of human lung cancer].
Nikiforova IF; Maksimishina MG; Lemekhov VG; Kniazev PG
Vopr Med Khim; 1991; 37(6):64-8. PubMed ID: 1687495
[TBL] [Abstract][Full Text] [Related]
18. Distribution of Ha-RAS-1 proto-oncogene alleles in breast cancer patients and in a control population.
Saglio G; Camaschella C; Giai M; Serra A; Guerrasio A; Peirone B; Gasparini P; Mazza U; Ceppellini R; Biglia N
Breast Cancer Res Treat; 1988 May; 11(2):147-53. PubMed ID: 2900032
[TBL] [Abstract][Full Text] [Related]
19. HRAS1 proto-oncogene polymorphisms in human malignant melanoma: TaqI defined alleles significantly associated with the disease.
Radice P; Pierotti MA; Borrello MG; Illeni MT; Rovini D; Della Porta G
Oncogene; 1987; 2(1):91-5. PubMed ID: 2894003
[TBL] [Abstract][Full Text] [Related]
20. Ha-ras restriction fragment length polymorphisms in colorectal cancer.
Wyllie FS; Wynford-Thomas V; Lemoine NR; Williams GT; Williams ED; Wynford-Thomas D
Br J Cancer; 1988 Feb; 57(2):135-8. PubMed ID: 2896015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
